4
Changes in Ownership
bioAffinity Technologies, Inc. Filed Acc 0001493152-22-033283
President, CEO bought 16,326 shares
- President, CEO acquired 23,672 shares (conversion)
- President, CEO acquired 18,099 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zannes Maria President, CEO | 2022-08-31 | Purchase | +16,326 | 19,897 | D | ||
| Zannes Maria President, CEO | 2022-09-06 | Conversion | +23,672 | $4.20 | $99,422 | 43,569 | D |
| Zannes Maria President, CEO | 2022-11-17 | Grant or award | +18,099 | 61,668 | D | ||
| Derivatives | |||||||
| Zannes Maria President, CEO | 2022-08-31 | Purchase · Warrants (right to buy) | +16,326 | 16,326 | D | ||
| Zannes Maria President, CEO | 2022-08-31 | Purchase · Non-tradeable Warrants (right to buy) | +16,326 | 16,326 | D | ||
| Zannes Maria President, CEO | 2022-09-06 | Conversion · Unsecured Convertible Promissory Note | −0 | 0 | D | ||
| Zannes Maria President, CEO | 2022-09-06 | Grant or award · Warrants (right to buy) | +23,571 | 23,571 | D | ||
| Open-market purchases · 16,326 sh | |||||||
Loading xslF345X03/ownership.xml…